top-banner

Non-Invasive Prenatal Testing

New generation NIPT for common genetic conditions

SELECT THE RIGHT TEST FOR YOU

With VERACITY and VERAgene, you have the option of taking a highly accurate (>99%) and safe non-invasive prenatal test (NIPT) to check for genetic conditions of the fetus before birth with no risk for miscarriage. In both NIPTs, cell-free DNA from the mother’s blood is analyzed to detect potential changes in the genome including aneuploidies and microdeletions. Additionally, VERAgene tests for single gene (monogenic) disorders in the biological parents. Both tests are recommended for any pregnant women, independent of age and risk category and can be done from 10th week of pregnancy. Choose VERACITY to detect the most common fetal aneuploidies and microdeletions which occur more frequent with advanced maternal age. Choose VERAgene if you additionally want to simultaneously screen for other microdeletions and monogenic diseases that do not have any maternal age-associated risk and can have a significant impact on life quality. The outcome of the test can help parents take informed decisions about possible treatments and clinical management.

VERACITY

Detection of the most common fetal aneuploidies and microdeletions (all included in VERAgene as well) which occur more frequent with advanced maternal age. VERACITY has been validated by several clinical studies for single and twin pregnancies, and can also be used in pregnancies conceived through in-vitro fertilization (IVF).

Learn more

VERAgene

Simultaneous screen for aneuploidies (included in VERACITY), microdeletions and monogenic diseases provides a comprehensive solution to prospective parents using a single test. Genetic diseases screened in VERAgene are associated with significant impact on life quality.

Learn more

Rhesus factor test

With non-invasive fetal Rhesus factor (RhD) determination, RhD negative pregnant women can have their blood tested to determine the RhD of their unborn child.

LATEST ARTICLES

February, designated as Cancer Awareness Month, marks a time to reflect on the remarkable progress made in cancer research and to inspire hope for th…

Read more

Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsible for mor…

Read more

Antimicrobial resistance (AMR) is one of the most pressing global health threats, and accurate identification and surveillance of multidrug-resistant…

Read more

Colorectal cancer remains a significant health concern globally. While genetic factors play a crucial role in its development, identifying the exact …

Read more

A new meta-analysis links trans-kingdom gut microbiota (bacteria, eukaryotes, viruses, archaea) to immune checkpoint inhibitor (ICI) response in canc…

Read more

Reproductive health is a fundamental aspect of human well-being, affecting individuals and communities worldwide [1]. It encompasses a wide range of …

Read more

It seems as though everyone is talking about artificial intelligence, usually referred to as AI, these days! Indeed, not only are AI tools now access…

Read more

Orphan drugs are those developed specifically for the treatment of rare diseases. Within the pharmaceutical industry, the drug development process is…

Read more

A study of 629 pregnancies with ultrasound-detected anomalies found that exome sequencing identified pathogenic variants in 14% of cases. The detecti…

Read more

Breast cancer is a type of cancer that originates in the breast cells. Genetic changes in the DNA of the healthy breast cells can lead to the formati…

Read more

OUR NETWORK